📖

events

wiki page Created: 2026-04-02T17:00:35 By: crosslink-v2 Quality: 50% ✓ SciDEX ID: wiki-events

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

232

Outgoing

268

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (500)

mentions🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar100%

mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction100%

mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br100%

mentions🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea100%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph100%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪SASP-Mediated Cholinergic Synapse Disruption65%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming65%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations65%

mentions🧪RNA Granule Nucleation Site Modulation65%

mentions🧪Cross-Seeding Prevention Strategy65%

mentions🧪PARP1 Inhibition Therapy65%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy65%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation65%

mentions🧪Complement C1q Subtype Switching65%

mentions🧪Mitochondrial Transfer Pathway Enhancement65%

mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation65%

mentions🧪LRP1-Dependent Tau Uptake Disruption65%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling65%

mentions🧪Arginine Methylation Enhancement Therapy65%

mentions🧪Autophagosome Maturation Checkpoint Control65%

mentions🧪Ganglioside Rebalancing Therapy65%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering65%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue65%

mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho65%

mentions🧪Extracellular Matrix Stiffness Modulation65%

mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution65%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism65%

mentions🧪Microglial Purinergic Reprogramming65%

mentions🧪CX43 hemichannel engineering enables size-selective mitochon65%

mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists65%

mentions🧪Axonal RNA Transport Reconstitution65%

mentions🧪Temporal Decoupling via Circadian Clock Reset65%

mentions🧪Lysosomal Positioning Dynamics Modulation65%

mentions🧪Ocular Immune Privilege Extension65%

mentions🧪Transcriptional Autophagy-Lysosome Coupling65%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming65%

mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics65%

mentions🧪Noradrenergic-Tau Propagation Blockade65%

mentions🧪Senescence-Induced Lipid Peroxidation Spreading65%

mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu65%

mentions🧪Smartphone-Detected Motor Variability Correction65%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering65%

mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu65%

mentions🧪Netrin-1 Gradient Restoration65%

mentions🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption65%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy65%

mentions🧪Lysosomal Calcium Channel Modulation Therapy65%

mentions🧪Glycine-Rich Domain Competitive Inhibition65%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 65%

mentions🧪Stress Granule Phase Separation Modulators65%

mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling65%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification65%

mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration65%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri65%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor65%

mentions🧪Mechanosensitive Ion Channel Reprogramming65%

mentions🧪VCP-Mediated Autophagy Enhancement65%

mentions🧪CYP46A1 Overexpression Gene Therapy65%

mentions🧪Piezoelectric Nanochannel BBB Disruption65%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna65%

mentions🧪Phase-Separated Organelle Targeting65%

mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi65%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis65%

mentions🧪Extracellular Vesicle Biogenesis Modulation65%

mentions🧪Multi-Modal Stress Response Harmonization65%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy65%

mentions🧪Nucleolar Stress Response Normalization65%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener65%

mentions🧪Vagal Afferent Microbial Signal Modulation65%

mentions🧪Lysosomal Membrane Repair Enhancement65%

mentions🧪Sphingolipid Metabolism Reprogramming65%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy65%

mentions🧪Flotillin-1 Stabilization Compounds65%

mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc65%

mentions🧪Adenosine-Astrocyte Metabolic Reset65%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu65%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

mentions🧫s:** - Temporal analysis showing mitochondrial defects prece60%

mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise60%

mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?60%

mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%

mentions🧫Prodromal Parkinson's Disease Biomarker Development — E60%

mentions🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%

mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin60%

mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%

mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther60%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%

mentions🧫Tau ASO Therapy60%

mentions🔬What are the minimal structural requirements for HSP70/HSP9060%

mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%

mentions🧫Prion Strain Diversity and Selective Vulnerability60%

mentions🧫Intensive Medical Treatment vs Usual Care in Women with ANOC60%

mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%

mentions🧫Cytochrome Therapeutics60%

mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model60%

mentions🧫Combination Therapy Sequencing in Parkinson's Disease60%

mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol60%

mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#60%

mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation60%

mentions🧫tACS Connectivity Trial in Early Alzheimer's60%

mentions🔬What is the therapeutic window between insufficient and toxi60%

mentions🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis60%

mentions🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%

mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%

mentions🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G60%

mentions🧫Parkinson's Disease Subtype Classification — Precision 60%

mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%

mentions🧫Literature Review of TRT-Induced Erythrocytosis Risk60%

mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto60%

mentions🧫Progranulin Replacement Therapy for FTD — Vector Development60%

mentions🧫Brainstem Circuit Modulation for PSP60%

mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%

mentions🧫PSP and CBS Biomarker Validation Study60%

mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#60%

mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%

mentions🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%

mentions🧫Genetic Risk Modifiers in DLB Phenotype60%

mentions🧫Experiment Validation: In vitro ThT Assay60%

mentions🧫N-of-1 Clinical Trial Design for CBS/PSP60%

mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%

mentions🧫Metabolic Pathway-Targeted Therapy in ALS60%

mentions🧫AAV-LRRK2 IND-Enabling Study Design60%

mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%

mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease60%

mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%

mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%

mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%

mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%

mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M60%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and60%

mentions🧫Confocal imaging of MSC-chondrocyte interactions during mito60%

mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson60%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection60%

mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%

mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%

mentions🧫In vitro DDR reconstitution on nucleosomes60%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau60%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 60%

mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel60%

mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%

mentions🧫Antiviral Therapy Trial for Parkinson's Disease60%

mentions🧫4R-Tau Targeting Therapies for PSP and CBS60%

mentions🧫Anti-Tau Immunotherapy Dosing Optimization60%

mentions🧫Neural Oscillation Dysfunction Validation in Parkinson'60%

mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%

mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%

mentions🧫Viral Infections and Alzheimer's Disease — causal mecha60%

mentions🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%

mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%

mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera60%

mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress60%

mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD60%

mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%

mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%

mentions🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%

mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%

mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%

mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%

mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%

mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in60%

mentions🧫Sleep Disruption and Alzheimer's Disease — mechanism an60%

mentions🧫TDP-43 PET Ligand Development for FTD and ALS60%

mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%

mentions🧫Experiment: Multi-Ethnic PD GWAS60%

mentions🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%

mentions🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%

mentions🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%

mentions🧫Prion Strain Diversity and Selective Vulnerability in CJD60%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP60%

mentions🧫VSMC cholesterol efflux and P2RY12 signaling60%

mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 60%

mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%

mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%

mentions🧫Ferroptosis Validation in Parkinson's Disease60%

mentions🧫PGC-1α knockout analysis of PV+ interneuron maturation60%

mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%

mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%

mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be60%

mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera60%

mentions🧫Alpha-Synuclein Seed Amplification Assay Validation60%

mentions🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%

mentions🧫IRF1 transcriptional regulation of Nlrc5 and Ciita promoters60%

mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%

mentions🧫Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr60%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%

mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD60%

mentions🧫Spp1 knockout prevents synaptic loss in AD mouse models60%

mentions🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech60%

mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap60%

mentions🧫Macroautophagy Dysfunction in PD - Experiment Design60%

mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di60%

mentions🧫Experiment: Autoimmune Hypothesis Testing in AD60%

mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%

mentions🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati60%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%

mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%

mentions🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%

mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

mentions🧫DLB Cognitive Fluctuation Mechanism Experiment60%

mentions🧫Experiment Scoring Methodology60%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be60%

mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%

mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%

mentions🧫NPH Glymphatic System Interaction Experiment60%

mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%

mentions🧫Tau Pathology Initiation Zone Identification60%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%

related🧪RNA Granule Nucleation Site Modulation58%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener58%

related🧪Serine/Arginine-Rich Protein Kinase Modulation58%

related🧪Noradrenergic-Tau Propagation Blockade58%

related🧪Arginine Methylation Enhancement Therapy58%

related🧪Ganglioside Rebalancing Therapy58%

related🧪Lysosomal Positioning Dynamics Modulation58%

related🧪Heat Shock Protein 70 Disaggregase Amplification58%

related🧪Glycine-Rich Domain Competitive Inhibition58%

related🧪CYP46A1 Overexpression Gene Therapy58%

related🧪Netrin-1 Gradient Restoration58%

related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption58%

related🧪Axonal RNA Transport Reconstitution58%

related🧪Piezoelectric Nanochannel BBB Disruption58%

related🧪Mitochondrial-Lysosomal Contact Site Engineering58%

related🧪Extracellular Vesicle Biogenesis Modulation58%

related🧪Extracellular Matrix Stiffness Modulation58%

related🧪Multi-Modal Stress Response Harmonization58%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis58%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy58%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu58%

related🧪Gamma entrainment therapy to restore hippocampal-cortical sy58%

related🧪Ocular Immune Privilege Extension58%

related🧪SASP-Mediated Cholinergic Synapse Disruption58%

related🧪SIRT6-NAD+ Axis Enhancement Therapy58%

related🧪Transcriptional Autophagy-Lysosome Coupling58%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming58%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy58%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi58%

related🧪Lysosomal Membrane Repair Enhancement58%

related🧪VCP-Mediated Autophagy Enhancement58%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation58%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc58%

related🧪CX43 hemichannel engineering enables size-selective mitochon58%

related🧪Complement C1q Subtype Switching58%

related🧪Adenosine-Astrocyte Metabolic Reset58%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 58%

related🧪Mechanosensitive Ion Channel Reprogramming58%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming58%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism58%

related🧪Smartphone-Detected Motor Variability Correction58%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations58%

related🧪Phase-Separated Organelle Targeting58%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling58%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho58%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering58%

related🧪PARP1 Inhibition Therapy58%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution58%

related🧪Sphingolipid Metabolism Reprogramming58%

related🧪Stress Granule Phase Separation Modulators58%

related🧪Autophagosome Maturation Checkpoint Control58%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor58%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna58%

related🧪Temporal Decoupling via Circadian Clock Reset58%

related🧪Nucleolar Stress Response Normalization58%

related🧪Cross-Seeding Prevention Strategy58%

related🧪Flotillin-1 Stabilization Compounds58%

related🧪LRP1-Dependent Tau Uptake Disruption58%

related🧪Microglial Purinergic Reprogramming58%

related🧪Lysosomal Calcium Channel Modulation Therapy58%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu58%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu58%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics58%

related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration58%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists58%

related🧪Vagal Afferent Microbial Signal Modulation58%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri58%

related🧪Mitochondrial Transfer Pathway Enhancement58%

related🧪Senescence-Induced Lipid Peroxidation Spreading58%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%

related🧫Blood-Based Biomarker Panel for Early AD Detection54%

related🧫N-of-1 Clinical Trial Design for CBS/PSP54%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%

related🧫Literature Review of TRT-Induced Erythrocytosis Risk54%

related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%

related🧫Prodromal Parkinson's Disease Biomarker Development — E54%

related🧫IRF1 transcriptional regulation of Nlrc5 and Ciita promoters54%

related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in54%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%

related🧫Proposed experiment from debate on Mitochondrial transfer be54%

related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati54%

related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%

related🧫Macroautophagy Dysfunction in PD - Experiment Design54%

related🧫Sleep Disruption and Alzheimer's Disease — mechanism an54%

related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 54%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%

related🧫Alpha-Synuclein Seed Amplification Assay Validation54%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther54%

related🧫Combination Therapy Sequencing in Parkinson's Disease54%

related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%

related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%

related🧫AAV-LRRK2 IND-Enabling Study Design54%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%

related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%

related🧫4R-Tau Targeting Therapies for PSP and CBS54%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%

related🧫Parkinson's Disease Subtype Classification — Precision 54%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera54%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G54%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%

related🧫CRISPR Gene Correction Approaches for CBS/PSP54%

related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%

related🧫Tau ASO Therapy54%

related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M54%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau54%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and54%

related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%

related🧫Intensive Medical Treatment vs Usual Care in Women with ANOC54%

related🧫Anti-Tau Immunotherapy Dosing Optimization54%

related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%

related🧫PGC-1α knockout analysis of PV+ interneuron maturation54%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%

related🧫tACS Connectivity Trial in Early Alzheimer's54%

related🧫Metabolic Pathway-Targeted Therapy in ALS54%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%

related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%

related🧫Viral Infections and Alzheimer's Disease — causal mecha54%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%

related🧫Cytochrome Therapeutics54%

related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%

related🧫Ferroptosis Validation in Parkinson's Disease54%

related🧫TDP-43 PET Ligand Development for FTD and ALS54%

related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%

related🧫s:** - Temporal analysis showing mitochondrial defects prece54%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%

related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech54%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%

related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%

related🧫NPH Glymphatic System Interaction Experiment54%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel54%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap54%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%

related🧫Normal Aging to Alzheimer's Disease Transition Trigger 54%

related🧫Experiment Validation: In vitro ThT Assay54%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%

related🧫Prion Strain Diversity and Selective Vulnerability54%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%

related🧫Confocal imaging of MSC-chondrocyte interactions during mito54%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%

related🧫Spp1 knockout prevents synaptic loss in AD mouse models54%

related🧫Experiment: Autoimmune Hypothesis Testing in AD54%

related🧫Antiviral Therapy Trial for Parkinson's Disease54%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%

related🧫Proposed experiment from debate on Mitochondrial transfer be54%

related🧫PSP and CBS Biomarker Validation Study54%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%

related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis54%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#54%

related🔬What is the therapeutic window between insufficient and toxi54%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%

related🧫Tau Pathology Initiation Zone Identification54%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%

related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%

related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%

related🧫Progranulin Replacement Therapy for FTD — Vector Development54%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%

related🧫VSMC cholesterol efflux and P2RY12 signaling54%

related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol54%

related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera54%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%

related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%

related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%

related🧫Experiment: Multi-Ethnic PD GWAS54%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation54%

related🧫Genetic Risk Modifiers in DLB Phenotype54%

related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto54%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%

related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%

related🧫Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr54%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%

related🧫In vitro DDR reconstitution on nucleosomes54%

related🧫Experiment Scoring Methodology54%

related🧫Brainstem Circuit Modulation for PSP54%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%

related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%

related🧫DLB Cognitive Fluctuation Mechanism Experiment54%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%

related🔬What are the minimal structural requirements for HSP70/HSP9054%

related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%

related🔬What are the mechanisms underlying sleep disruption as cause50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

mentions🧪Glycosaminoglycan Template Disruption Approach50%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

mentions🧪APOE Isoform Conversion Therapy50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR50%

mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%

mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

mentions🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%

related🔬Investigate prion-like spreading of tau pathology through co50%

mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

mentions🧪Transglutaminase-2 Cross-Linking Inhibition Strategy50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪Optogenetic Control of Mitochondrial Transfer Networks50%

mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%

mentions🧪Oligodendrocyte White Matter Vulnerability50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 44%

mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha44%

mentions🧫TRIM21-mediated K63-linked ubiquitination of G3BP144%

mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise44%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp39%

related🔬What are the mechanisms underlying tdp-43 phase separation t39%

related🔬What are the mechanisms underlying selective vulnerability o39%

events

💬 Discussion